WHO: an inspection to evaluate Sputnik V will take place no earlier than January 2022 V will take place no earlier than January 2022. This was reported by the press service of the World Health Organization (WHO), RIA Novosti reports.
WHO representatives met with members of the Russian Direct Investment Fund (RDIF) to discuss the need for additional information on the quality, safety and efficacy of the vaccine .
“The company has pledged to provide a detailed roadmap for submitting data so that WHO can accelerate the evaluation of the vaccine,” the report says.
Earlier, the head of RDIF Kirill Dmitriev explained the delay in approval of the Russian vaccine against coronavirus “Sputnik V” by WHO. According to him, the obstacles are purely bureaucratic.
At the moment, Sputnik V is registered in 70 countries, with a total population of about four billion people. The drug is manufactured by more than 20 companies in 14 countries around the world.